(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxohexadecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide

To understand the chemical structure of this " (4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indeno [5,4-f] quinoline-7-formamide", it is necessary to follow the principles of organic chemistry.
In the nomenclature of this compound, many stereochemical labels, such as " (4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) ", indicate a specific atomic spatial arrangement. " N-tert-butyl ", indicating that the nitrogen atom is connected with tert-butyl. Tert-butyl is a hydrocarbon group with a specific structure, such as" -C (C H ₃)₃” 。
"4a, 6a-dimethyl", indicating that there is methyl substitution at the 4a and 6a positions. "2-oxo", that is, the 2-position carbon atom is connected to the oxygen atom with a double bond to form a carbonyl structure. " Hexadecyl-1H-indeno [5,4-f] quinoline "reveals the basic skeleton, which is formed by the fusing of indene and quinoline, and has sixteen hydrogen atoms, and its skeleton has a specific ring system and atomic connection." -7-formamide "is a 7-position formamide group, and the formamide group is a" -CONH ² "structure.
Overall, this compound uses indenoquinoline as the skeleton, and has methyl, carbonyl, tert-butyl and formamide groups at specific positions. Each atom is arranged in a specific space according to the stereochemical identification, forming a unique chemical structure.

(4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indeno [5,4-f] quinoline-7-formamide The physical properties of this substance are quite critical.
Looking at its morphology, at room temperature, it is mostly in the state of white to off-white crystalline powder, which is the most intuitive representation in appearance. As for the color, the pure one is as white as snow, if there are slight impurities, or yellowish. < Br >
When it comes to solubility, this substance exhibits good solubility in organic solvents, such as dichloromethane, N, N-dimethylformamide, and can be fused with it. However, in water, the solubility is poor and it is difficult to disperse and dissolve. This property is closely related to the hydrophobicity of the groups contained in its molecular structure.
Its melting point is also one of the important physical properties. After careful determination, the melting point is about a certain temperature range. This temperature range is of great significance for the identification and purification of this compound, and can be used as a key indicator for quality control.
In addition, density is also a factor to consider. Its density has been accurately measured and has a specific value. Although the density value seems ordinary, it has a non-negligible role in many fields such as chemical production and preparation research and development. It is related to the actual operation of the quantity and mixing ratio of substances.
The physical properties of this compound are fundamental and important information in many fields such as chemical research, drug development, and materials science, laying the foundation for subsequent applications and exploration.

To prepare (4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indeno [5,4-f] quinoline-7-formamide, the synthesis method is a complicated and delicate process.
Initially, suitable starting materials need to be prepared, which are based on aromatic hydrocarbons and nitrogen-containing heterocyclic compounds containing specific substituents. First, the aromatic hydrocarbons are subjected to a delicate halogenation reaction, and a halogen atom is introduced. This halogen atom is like a key to opening the subsequent reaction. The halogenated reagents used should be carefully selected according to the reaction conditions and the characteristics of the substrate, such as halogen elements, hydrogen halides or specific halogenating agents.
Then, the nucleophilic substitution reaction of the halogenated aromatic hydrocarbons with nitrogen-containing heterocyclic compounds is carried out. This step requires precise regulation of the reaction temperature, reaction time and reaction medium to ensure that the reaction advances in the expected direction. The reaction medium is either an organic solvent or a mixed solvent system. Its polarity, solubility and other properties have a great impact on the reaction process.
After the nucleophilic substitution product is formed, it needs to undergo multi-step functional group transformation. During this time, it may involve oxidation, reduction, acylation and other reactions. The oxidation reaction aims to precisely construct functional groups such as carbonyl groups, and the strength and selectivity of the oxidizing agent used are crucial; the reduction reaction can adjust the oxidation state of some groups in the molecule as needed; the acylation reaction can introduce key amide structural units.
In the synthesis process, the control of stereochemistry is also of paramount importance. Because the target product has multiple chiral centers, in order to obtain high stereoselectivity products, special catalysts or chiral auxiliaries must be used. Chiral catalysts act as the helmsman of the reaction, guiding the reaction to selectively generate products of a specific configuration. Chiral catalysts of certain metal complexes or chiral auxiliaries derived from natural products can play this key role under suitable conditions.
After each step of the reaction, the product needs to be separated and purified. Commonly used methods include column chromatography, recrystallization, etc. Column chromatography can separate the target product from impurities according to the polarity of the compound; recrystallization can further purify the product by different solubility to obtain high purity (4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indeno [5,4-f] quinoline-7-formamide.

(4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indeno [5,4-f] quinoline-7-formamide, this is a complex organic compound with a wide range of application fields.
In the field of pharmaceutical research and development, this compound may have unique biological activities or can be combined with specific biological targets. By regulating physiological and biochemical processes in organisms, it has therapeutic potential for diseases such as inflammation and tumors. Due to its specific chemical structure, the cap may precisely regulate the signaling pathway at the cellular level and inhibit the abnormal proliferation and differentiation of disease-related cells.
In the field of materials science, its structural properties may endow materials with special properties. Or it can be used as a key component of functional materials, such as in photoelectric materials, or it can regulate the optical and electrical properties of materials, and can be used in organic Light Emitting Diodes (OLEDs), solar cells and other devices to improve their performance and efficiency.
Furthermore, in the field of organic synthetic chemistry, this compound can be used as an important synthesis intermediate. Due to its complex structure containing a variety of functional groups, chemists can use various organic reactions to modify and derivatize their structures, synthesize more organic compounds with novel structures and unique properties, expand the chemical boundaries of organic synthesis, and provide rich compound resources for new drug development and new material creation.
In summary, (4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indo [5,4-f] quinoline-7-formamide has important application value and research significance in many fields such as medicine, materials, and organic synthesis.

(4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indo [5,4-f] quinoline-7-formamide, this is an organic compound that may be of great significance in the fields of medicinal chemistry and organic synthesis chemistry. However, looking at its market prospects, due to the lack of detailed data, it can only be speculated one or two from the general situation in related fields.
In the field of drug development, if the compound has unique biological activity, it may become an innovative drug lead compound. Today, the demand for new therapeutic drugs continues to rise, especially for major diseases such as cancer and neurological diseases. If this compound is proven to have effects on specific disease targets, pharmaceutical companies may invest resources in in-depth research and development. And with the advancement of drug development technology, the possibility of discovering more potential medicinal value of this compound is also increasing.
In the field of organic synthesis, if the compound has a unique structure, it can be used as an intermediate in organic synthesis, providing a way for the synthesis of other complex organic molecules. With the development of materials science, fine chemicals and other industries, the demand for special structural organic compounds may increase, and this compound may usher in application opportunities due to its own structural characteristics.
However, its marketing activities also face challenges. The development of organic compounds to practical application requires many rigorous tests and approvals. Drug research and development must go through preclinical research, clinical trials and other stages, which takes a long time and costs a lot. Many compounds die during research and development or due to various reasons. Furthermore, the market competition is fierce, and it is not easy for the compound to stand out if other similar structural or functional compounds have occupied the market.
Overall, (4aR, 4bS, 6aS, 7S, 9aS, 9bS, 11aR) -N-tert-butyl-4a, 6a-dimethyl-2-oxohexadecyl-1H-indo [5,4-f] quinoline-7-formamide has addressable market opportunities, but in order to realize its market value, it is still necessary for researchers and enterprises to work together, and it can be clarified through in-depth research and development.